BIRCHBIOMED
  • HOME
  • ABOUT US
  • OUR SCIENCE
  • COMPETITIVE ADVANTAGES
  • OUR TEAM
  • PUBLISHED MEDICAL LINKS
  • IN THE NEWS
  • CONTACT
  • Search
  • Menu Menu

Home_page4

December 4, 2015/by SteveSmiley

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
http://www.birchbiomed.com/wp-content/uploads/2015/11/birchbiomed1.png 0 0 SteveSmiley http://www.birchbiomed.com/wp-content/uploads/2015/11/birchbiomed1.png SteveSmiley2015-12-04 15:00:172015-12-04 15:00:17Home_page4

Recent Comments

    Archives

    Categories

    • No categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    About BirchBioMed

    BirchBioMed is a clinical-stage biomedical company focused on the commercialization, clinical evaluation and development of proprietary anti-scarring drugs, autoimmune therapeutics/ therapies and novel strategies for transplantation.

    New York

    866.350.1993

    Toronto

    905.833.0826

    Vancouver

    778.989.5104

    In The News

    BirchBioMed welcomes renowned dermatologist to its board of directors

    Birchbiomed announces completion of clinical trial for ground-breaking anti-scarring drug

    UBC Develops Anti-scarring Drug

    CKNW – Sean Leslie Show – Fibrostop, a Drug to Help Burn Victims

    SITE MENU

    • HOME
    • ABOUT US
    • IN THE NEWS
    • OUR SCIENCE
    • OUR TEAM
    • COMPETITIVE ADVANTAGES
    • CONTACT
    ©2021 BirchBioMed. All rights reserved.
    • HOME
    • ABOUT US
    • IN THE NEWS
    • OUR SCIENCE
    • OUR TEAM
    • COMPETITIVE ADVANTAGES
    • CONTACT
    Scroll to top